Hvilken er prisen på Kexing Biopharm Co., Ltd. (688136)

Prisen på Kexing Biopharm Co., Ltd. (688136) er $3.13

Hva er markedsverdien på Kexing Biopharm Co., Ltd. (688136)

Markedsverdien på Kexing Biopharm Co., Ltd. (688136) er $621.33M

Kexing Biopharm Co., Ltd. (688136) Driftsmargin

Kexing Biopharm Co., Ltd. is a global pharmaceutical enterprise primarily involved in the exploration, manufacturing, and commercialization of advanced recombinant protein-based drugs and microbial preparations, serving both the Chinese domestic market and international clientele. The company strategically directs its research and development endeavors towards crucial medical areas, specifically focusing on antiviral therapies, oncology, immunology, hematological conditions, digestive system health, and degenerative diseases. Its extensive product lineup features diverse pharmaceutical solutions. This includes innovative recombinant human proteins such as interferon a1b, erythropoietin, and granulocyte stimulating factor. Additionally, their offerings encompass microbial formulations like Clostridium butyricum combined live bacteria powder, traditional Chinese patent medicines (e.g., Kehuang Capsule), and chemical drugs like Entecavir. Kexing Biopharm also provides cutting-edge biologics, including liraglutide (a human glucagon-like peptide-1), along with other specialized therapeutics such as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab, neratinib maleate tablets, and lenalidomide capsules. Established in 1989, the company's main operations are situated in Jinan, China.

År	Driftsmargin	Endre
Ikke nok data for de angitte datoene.

År

Driftsmargin

Endre

Ikke nok data for de angitte datoene.

Selskap	Driftsmargin	Forskjell i driftsmargin	Land
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
CSL Limited CSL.AX	25.72%	-	AU
Moderna, Inc. MRNA.US	-149.01%	-	US
Lonza Group AG LONN.SW	0.00%	-	CH

Selskap

Driftsmargin

Forskjell i driftsmargin

Land